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Translating Best Evidence into Best Care
EDITOR’S NOTE: Studies for this column are identified using the Clinical Queries feature of PubMed, “hand” searching JAMA,
JAMA Pediatrics, Pediatrics, The Journal of Pediatrics, and The New England Journal of Medicine, and from customized
EvidenceUpdates alerts.
EBM PEARL: MULTIPLE LOGISTIC REGRESSION (MLR): Researchers use MLR to identify characteristics
that may affect an outcome of interest. Cain et al (below) employed MLR to assess the influence of various patient character-
istics on whether or not a child presenting with headaches received neuroimaging (the outcome of interest). In MLR language,
neuroimaging is the dependent variable and is binary (yes/no). The patient characteristics included white race, no headache
history, no similar headaches in the past, vision changes, speech difficulty, weakness, altered mental status, and others. The initial
step was to perform univariate logistic regression, testing the effect of each individual patient characteristic on whether the child
received neuroimaging. Those patient characteristics (that met certain statistical criteria) that were statistically-significantly as-
sociated with receiving neuroimaging were then evaluated with MLR. This second step evaluated each of the chosen statistically-
significant patient characteristics in relation to all the others. Some of the characteristics ended up not statistically significant
in this analysis due to strong correlation (overlap) among 2 or more characteristics. The result of the MLR analysis was a smaller
set of independently associated, statistically-significant patient characteristics that affected the decision to image the patient:
any abnormal neurologic finding, no similar headaches in the past, and white race. These were the primary findings of the Cain
et al study (commentary below).
CRITICAL STATISTICAL DISTINCTION PEARL: STATISTICAL TESTS FOR BINARY VS CON-
TINUOUSDATA: EBM learners of all levels may not realize that many statistical terms and tests use only one type of data.
An important “critical distinction” in EBM is the practical use of binary and continuous data. Here are 5 helpful hints: 1) Ex-
amples of binary data include: headaches present (yes/no) and headaches improved (>50%/<50%). 2) Examples of continu-
ous data include blood pressure and age measures (mean +/− standard deviation). 3) Statistics that employ binary data include
likelihood ratios, sensitivity, specificity, absolute risk reduction, relative risk, odds ratio and the Chi square test. 4) Statistics
that employ continuous data include ANOVA and paired and independent t-tests. 5) Finally, 95% confidence intervals may be
used for both types of data.
—Jordan Hupert, MD
Patient characteristics and neuroimaging for
headache in the ED
Cain MR, Arkilo D, Linabery AM, Kharbanda AB. Emer-
gency Department Use of Neuroimaging in Children and Ado-
lescents Presenting with Headache. J Pediatr 2018;201:196-201.
Question Among children presenting to the emergency de-
partment (ED) with headache, what is the association of patient
characteristics and neuroimaging?
Design Prospective cohort.
Setting Two pediatric EDs in Minnesota.
Participants 294 children, 6-18 years old, with headache.
Intervention Patient characteristics.
Outcomes Neuroimaging (CT or MRI).
Main Results 0.7% (95% CI, 0.1%-2.4%) and 3.8% (95% CI,
0.5%-13%) of all and of the 53 patients undergoing
neuroimaging, respectively, demonstrated clinically impor-
tant intracranial findings. Abnormal neurologic findings, new-
type headache, and white race were all associated with
undergoing neuroimaging.
Conclusions The low clinically-important-intracranial-
finding rate suggests the need for more refined algorithm de-
velopment based on large study populations. Bias in the odds
of receiving neuroimaging should be addressed.
Commentary Cain et al bring attention to the public health
problem at hand: a large proportion of children with head-
aches are undergoing unnecessary neuroimaging and are
exposed to the risks of morbidity and mortality associated with
CT scans and MRIs. Conducted in 2 EDs, their findings reflect
the high rate of neuroimaging in children with non-traumatic
headaches described both nationally (36%) and at our own
center (33%), the latter in which we described a similarly low
prevalence of emergent intracranial abnormalities (1%).1,2 The
risk factors identified for receiving ED neuroimaging in chil-
dren with headaches are important when looking to change
behavior in clinicians. However, as noted by the authors, the
million-dollar question remains: which risk factors should be
used to determine if a child with headache requires ED
neuroimaging? Similar to other studies preceding Cain et al,
the number of outcomes is too small to adequately answer this
question. Larger prospective studies are necessary to move
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beyond identifying risk factors for receiving ED neuroimaging
to identifying risk factors associated with emergent intracra-
nial abnormalities. These studies should develop clinical pre-
diction rules or risk stratification models that can serve as the
basis for standardizing and optimizing the evaluation of chil-
dren with headaches, with the hope of preventing further harm
associated with unnecessary ED neuroimaging.
Daniel S. Tsze,MD
Columbia University College of Physicians and Surgeons
New York, New York
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Neither fluid rate nor sodium content affect
neurocognitive outcomes in DKA
Kuppermann N, Ghetti S, Schunk JE, Stoner MJ, Rewers A,
McManemy JK. Clinical Trial of Fluid Infusion Rates for Pe-
diatric Diabetic Ketoacidosis. N Engl J Med 2018;378:2275-87.
Question Among children with diabetic ketoacidosis (DKA)
what is the effect of intravenous fluid administration (IVF) rate
and sodium content on the incidence of neurocognitive injury?
Design 2 × 2 factorial, randomized controlled trial.
Setting 13 emergency departments in the Pediatric Emer-
gency Care Applied Research Network (PECARN).
Participants 1255 children (0-18 years) with 1389 DKA
episodes.
Intervention Fast vs slow IVF administration rate and 0.9%
vs 0.45% normal saline.
Outcomes Primary outcome: 2 consecutive Glasgow Coma
Scale (GCS) scores of <14 among children presenting with
scores of 14 or 15. Secondary outcome: clinically apparent brain
injury.
Main Results There were no differences in any of the
neurocognitive outcomes.
Conclusions Neither fluid rate nor salinity affected
neurocognitive outcomes in DKA.
Commentary Thirty years ago, it was suggested that fluid rates
exceeding 4L/meter2/24h increased the risk of cerebral edema.1
A potential causal association between the rate or sodium chlo-
ride content of IVF administration for the treatment of DKA
and the development of DKA-related brain injury (cerebral
edema) continues to be controversial.2 The PECARN DKA
FLUID Study Group conducted a 13-center RCT in children
with DKA comparing fluid with 0.9% sodium chloride vs 0.45%
sodium chloride. Each was infused at either a slower rate (even
fluid replacement over 48 hours) or a faster rate (half the deficit
replaced in 12 hours and the remainder over the subsequent
24 hours). No significant differences were observed in the fre-
quency of either altered mental status or clinically apparent
brain injury in any of the treatment arms, and long-term
neurocognitive outcomes were similar in all groups. It is also
notable that in the subgroups of patients with more severe DKA,
the percentage of episodes in which the GCS score declined
to below 14 and the percentage of episodes with clinically con-
firmed apparent brain injury did not differ significantly among
the groups. Edema may be a consequence rather than the cause
of brain injury, and other mechanisms, in particular ischemia-
reperfusion injury and neuroinflammation resulting in blood-
brain barrier dysfunction, need to be explored.2,3 This study
shows that clinicians should not unnecessarily restrict fluid ad-
ministration if clinical signs suggest the need for circulatory
volume expansion. Rapid overhydration should be avoided;
however, there is a risk that unduly cautious fluid resuscita-
tion might prolong the cytotoxic effects of dehydration and
acidosis. It is notable that impaired brain function occurred
predominantly in patients who had more severe acidosis and
a lower pCO2 level, which suggests that such patients require
even more careful clinical and biochemical monitoring.
JosephWolfsdorf,MB, BCh
Boston Children’s Hospital
Boston, Massachusetts
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2-6 years-of-age is the period associated with
greatest BMI acceleration among
obese adolescents
Geserick M, Vogel M, Gausche R, Lipek T, Spielau U, Keller
E, et al. Acceleration of BMI in Early Childhood and Risk of
Sustained Obesity. N Engl J Med 2018;379:1303-12.
Question Among children and adolescents, what is the lon-
gitudinal, year-specific association of BMI in childhood with
BMI in adolescence?
Design Retrospective and prospective secondary analysis of the
CrescNet German patient registry.
Setting Germany.
Participants Sample of 51 505 children with longitudinal an-
thropometric data in childhood (0-14 years) and adoles-
cence (15-18 years).
Intervention BMI progression in childhood.
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OutcomesYear-specific association of BMI’s in childhood and
adolescence.
Main Results Most adolescents with normal weight always had
a normal weight. Ninety percent of obese 3-year-olds were over-
weight or obese in adolescence. The greatest BMI accelera-
tion occurred between 2-6 years of age.
Conclusions Obesity at a very young age is associated with
obesity in adolescence, with 2-6 years of age being the period
of greatest weight gain.
Commentary This study provides empirical data on growth
trajectories from infancy to adolescence and finds that early
childhood may be a critical period for excess weight gain. Al-
though it provides important information on the dynamics of
growth trajectories, it is not clear how these findings based on
retrospective data should best be used to inform practice for
today’s children. Specific obesogenic factors were not identi-
fied in the study, and given the many changes in environmen-
tal influences in recent years, the causes of excess weight gain
among study participants from previous cohorts may not be
the same as for current children. In addition, focusing on a
“high-risk” age group may not translate into an effective long-
term prevention strategy as efforts to prevent excess weight in
this age group may simply defer weight gain to later ages. Sus-
tained obesity prevention efforts across the life course may be
more effective than trying to intervene in “critical periods.”
Further work to identify the underlying factors which con-
tribute to excess weight gain would help to contextualize results
from retrospective studies for today’s children and help design
specific interventions.
Zachary J. Ward,MPH
Harvard T.H. Chan School of Public Health
Boston, Massachusetts
Maternal voice smoke alarms outperform tone
alarms in waking grammar-school-age
children
Smith GA, Chounthirath T, Splaingard M. Effectiveness of a
Voice Smoke Alarm with the Child’s Name for Sleeping Chil-
dren: A Randomized Trial. J Pediatr;205:250-6.
Question Among grammar-school-age children, what is the
efficacy of a maternal voice smoke alarm (using the child’s
name, escape instructions, or both), compared with a tone
alarm, in waking and escaping rates?
Design Randomized, nonblinded, repeated measures design.
Setting Research setting with a replica residential bedroom,
Columbus, Ohio.
Participants Children 5-12 years old.
Intervention Voice vs tone smoke alarm.
Outcomes Waking and escaping rates.
Main Results The median times to awaken was 156.0 (6.0-
>300) seconds for the tone alarm and 2.0 (1.0-~6.0) seconds
the voice alarms. The absolute risk reduction for voice com-
pared with tone was 37.5% (95% CI, 29.0%-46.0%); the
number needed to treat was 3 (95% CI, 3-4). Similar results
were noted for waking and completing a simulated escape
procedure.
Conclusions A maternal voice smoke alarm outperformed a
tone alarm.
Commentary The prevention of residential fire deaths among
school-aged children has been hindered because children at
that age usually do not wake up to typical high frequency smoke
alarms. Since these children can participate in their own escape
from a house fire, finding an alarm type that is effective in
waking them up could significantly improve their chances of
successful escape. Smith et al report a follow up to their pre-
vious smaller trial, which in 2006 showed significant promise
of a smoke alarm that used maternal voice rather than a tone.1
In the current study of 176 children aged 5-12 years who slept
in a research setting to mimic a residential environment, the
maternal voice alarm dramatically outperformed the tradi-
tional tone alarm. With the maternal voice alarm, a far greater
proportion of children in Stage 4 sleep woke up, woke up
quicker, and succeeded in a simulated escape compared with
the tone alarm. This is an advance that has real potential to
save children’s lives. This work would be furthered by careful
evaluation of whether any voice works this well or if the child’s
mother’s voice is key. If each family has to record their own
voice alarm, this would add cost and might not be as widely
accepted. The voice alarm should also be compared with the
low frequency (520-Hz square wave) tone alarm adopted as
the national standard in 2014.2
Kyran Quinlan,MD,MPH
Rush University Medical Center
Chicago, Illinois
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Minitablets may be an acceptable alternative
to liquid in infants and young children
Klingmann V, Linderskamp H, Meissner T, Mayatepek E,
Moeltner A, Breitkreutz J, et al. Acceptability of Multiple Un-
coated Minitablets in Infants and Toddlers: A Randomized Con-
trolled Trial. J Pediatr 2018;201:202-7.
Question Among infants and toddlers/young children, how
do minitablet placebos compare with liquid placebos, in ac-
ceptability and swallowability?
DesignOpen, randomized, single dose, 3-way cross-over design.
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Setting A single center in Dusseldorf, Germany.
Participants Infants (6-23 months) and toddlers/young chil-
dren (2-5 years).
Intervention Minitablet (25 and 100 minitablets in infants,
100 and 400 in toddlers/young children) vs liquid placebos.
Outcomes Acceptability and swallowability.
Main ResultsAmong infants, both 25 and 100 minitablets were
statistically superior to liquid for both acceptability and
swallowability. In toddlers/young children acceptability was
noninferior for 400 minitablets (but not 100) compared with
liquid; swallowability was noninferior for 100 but not 400
minitablets compared with liquid.
Conclusions Minitablets are a superior alternative to liquid
in infants. In older children, 400 minitablets are an accept-
able alternative to liquid.
Commentary Acceptability of minitablets in children is im-
portant to those working in pharmaceutical development to
ensure medicines meet the needs of patients. Previous work
showed that tablets are superior to alternative oral formula-
tions in children aged 1-4 years.1 Klingmann et al provide evi-
dence that multiple minitablets (up to 400) are accepted by
children aged 2-5 years. The study is limited by ethical re-
quirements to include only children who are able to swallow
and are compliant and willing to accept the study procedures
both of which may introduce bias in study outcomes. Reluc-
tance to use solid dosage forms is often attributed to risks as-
sociated with choking yet no deglutition issues were detected
with minitablets in a total of 372 participants. Taste is not an
issue for placebo minitablets, which may not be valid for a com-
mercial product. Future work should focus on the acceptabil-
ity of commercial minitablets, with the associated hurdles
associated with a real pediatric population and a real drug
product.
Hannah Batchelor, BSc, PhD
University of Birmingham
Birmingham, United Kingdom
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